D.E. Shaw & Co’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Sell |
1,484,098
-176,280
| -11% | -$455K | ﹤0.01% | 2461 |
|
|
2025
Q4 | $2.24M | Buy |
1,660,378
+251,575
| +18% | +$366K | ﹤0.01% | 2962 |
|
|
2025
Q3 | $2.13M | Buy |
1,408,803
+211,179
| +18% | +$317K | ﹤0.01% | 2931 |
|
|
2025
Q2 | $1.39M | Buy |
1,197,624
+79,847
| +7% | +$105K | ﹤0.01% | 3006 |
|
|
2025
Q1 | $1.78M | Sell |
1,117,777
-121,682
| -10% | -$262K | ﹤0.01% | 2694 |
|
|
2024
Q4 | $3.76M | Buy |
1,239,459
+110,882
| +10% | +$363K | ﹤0.01% | 2216 |
|
|
2024
Q3 | $4.15M | Buy |
1,128,577
+888,236
| +370% | +$3.23M | 0.01% | 2096 |
|
|
2024
Q2 | $983K | Buy |
240,341
+226,050
| +1,582% | +$2.52M | ﹤0.01% | 3221 |
|
|
2024
Q1 | $225K | Buy |
+14,291
| New | +$197K | ﹤0.01% | 3878 |
|
|
2023
Q4 | – | Sell |
-37,439
| Closed | -$751K | – | 4725 |
|
|
2023
Q3 | $751K | Buy |
+37,439
| New | +$950K | ﹤0.01% | 3238 |
|
|
2022
Q4 | – | Sell |
-29,112
| Closed | -$631K | – | 5220 |
|
|
2022
Q3 | $631K | Sell |
29,112
-25,633
| -47% | -$701K | ﹤0.01% | 3893 |
|
|
2022
Q2 | $1.54M | Buy |
54,745
+33,786
| +161% | +$895K | ﹤0.01% | 3298 |
|
|
2022
Q1 | $967K | Buy |
20,959
+2,867
| +16% | +$155K | ﹤0.01% | 3945 |
|
|
2021
Q4 | $1.52M | Sell |
18,092
-36,346
| -67% | -$2.81M | ﹤0.01% | 3598 |
|
|
2021
Q3 | $3.63M | Sell |
54,438
-2,016
| -4% | -$116K | ﹤0.01% | 2433 |
|
|
2021
Q2 | $3M | Buy |
56,454
+34,283
| +155% | +$1.84M | ﹤0.01% | 2529 |
|
|
2021
Q1 | $962K | Sell |
22,171
-23,116
| -51% | -$995K | ﹤0.01% | 3145 |
|
|
2020
Q4 | $2.35M | Buy |
45,287
+37,294
| +467% | +$1.68M | ﹤0.01% | 2452 |
|
|
2020
Q3 | $261K | Sell |
7,993
-16,942
| -68% | -$593K | ﹤0.01% | 3505 |
|
|
2020
Q2 | $1.2M | Buy |
+24,935
| New | +$956K | ﹤0.01% | 2797 |
|
Other funds holding ZNTL
5VM
SCM
VCM
OM
DC
